Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway.
暂无分享,去创建一个
Hao Jiang | Qiang Wen | Haitao Wang | Hao Jiang | P. Lazarovici | Wenhua Zheng | Haitao Wang | Q. Wen | Philip Lazarovici | Qishan Zhang | Yongxin Zheng | Jun Lin | WenHua Zheng | Qishan Zhang | Jun Lin | Yongxin Zheng
[1] S. Kane,et al. A Method to Identify Serine Kinase Substrates , 2002, The Journal of Biological Chemistry.
[2] Wenhua Zheng,et al. FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling , 2002, Journal of neurochemistry.
[3] M. Birnbaum,et al. Akt1/PKBα Is Required for Normal Growth but Dispensable for Maintenance of Glucose Homeostasis in Mice* , 2001, The Journal of Biological Chemistry.
[4] J. Zierath,et al. Insulin Receptor Substrate-1 Phosphorylation and Phosphatidylinositol 3-Kinase Activity in Skeletal Muscle From NIDDM Subjects After In Vivo Insulin Stimulation , 1997, Diabetes.
[5] C. MacKintosh,et al. Regulation of the 14-3-3-binding protein p39 by growth factors and nutrients in rat PC12 pheochromocytoma cells. , 2002, The Biochemical journal.
[6] D. Sabatini. mTOR and cancer: insights into a complex relationship , 2006, Nature Reviews Cancer.
[7] Chin-Lee Wu,et al. Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway , 2009, PloS one.
[8] R. Quirion,et al. Insulin-like Growth Factor-1-induced Phosphorylation of the Forkhead Family Transcription Factor FKHRL1 Is Mediated by Akt Kinase in PC12 Cells* , 2000, The Journal of Biological Chemistry.
[9] S. Masters,et al. Survival-promoting functions of 14-3-3 proteins. , 2001, Biochemical Society transactions.
[10] S. Kane,et al. Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. , 2005, Diabetes.
[11] Lewis C. Cantley,et al. AKT/PKB Signaling: Navigating Downstream , 2007, Cell.
[12] C. Lang,et al. PRAS40 Regulates Protein Synthesis and Cell Cycle in C2C12 Myoblasts , 2010, Molecular medicine.
[13] J. Gusella,et al. NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth , 2009, Molecular and Cellular Biology.
[14] S. Huh,et al. Targeting Akt3 Signaling in Malignant Melanoma Using Isoselenocyanates , 2009, Clinical Cancer Research.
[15] G. Mills,et al. Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis. , 2010, Cancer research.
[16] X. Lu,et al. Overexpression of osteopontin induces angiogenesis of endothelial progenitor cells via the avβ3/PI3K/AKT/eNOS/NO signaling pathway in glioma cells. , 2011, European journal of cell biology.
[17] G. Dohm,et al. Insulin activation of phosphatidylinositol 3-kinase in human skeletal muscle in vivo. , 1997, Journal of applied physiology.
[18] C. Proud,et al. PRAS40 Is a Target for Mammalian Target of Rapamycin Complex 1 and Is Required for Signaling Downstream of This Complex* , 2007, Journal of Biological Chemistry.
[19] G. Thomas,et al. mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer. , 2007, Trends in molecular medicine.
[20] W. Sessa,et al. Targeting of Endothelial Nitric-oxide Synthase to the Cytoplasmic Face of the Golgi Complex or Plasma Membrane Regulates Akt- Versus Calcium-dependent Mechanisms for Nitric Oxide Release* , 2004, Journal of Biological Chemistry.
[21] R. Roth,et al. PRAS40 Regulates mTORC1 Kinase Activity by Functioning as a Direct Inhibitor of Substrate Binding* , 2007, Journal of Biological Chemistry.
[22] A. Gomez-Muñoz,et al. Activation of mTOR and RhoA is a major mechanism by which Ceramide 1-phosphate stimulates macrophage proliferation. , 2011, Cellular signalling.
[23] J. Javitch,et al. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. , 2010, The American journal of psychiatry.
[24] K. Maiese,et al. Activating Akt and the brain's resources to drive cellular survival and prevent inflammatory injury. , 2005, Histology and histopathology.
[25] G. Ruvkun,et al. Phosphatidylinositol 3-Kinase Signaling Inhibits DAF-16 DNA Binding and Function via 14-3-3-dependent and 14-3-3-independent Pathways* , 2001, The Journal of Biological Chemistry.
[26] Joe W. Gray,et al. PIK3CA is implicated as an oncogene in ovarian cancer , 1999, Nature Genetics.
[27] Lewis C Cantley,et al. The phosphoinositide 3-kinase pathway. , 2002, Science.
[28] J. Avruch,et al. Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action , 2002, Cell.
[29] H. Pijl,et al. Loss of 50% of excess weight using a very low energy diet improves insulin-stimulated glucose disposal and skeletal muscle insulin signalling in obese insulin-treated type 2 diabetic patients , 2007, Diabetologia.
[30] J. Eckel,et al. Insulin-Mediated Phosphorylation of the Proline-Rich Akt Substrate PRAS40 Is Impaired in Insulin Target Tissues of High-Fat Diet–Fed Rats , 2006, Diabetes.
[31] D. Alessi,et al. TSC1–TSC2: a complex tale of PKB-mediated S6K regulation , 2002, Nature Cell Biology.
[32] K. Kaestner,et al. Insulin Resistance and a Diabetes Mellitus-Like Syndrome in Mice Lacking the Protein Kinase Akt2 (PKBβ) , 2001 .
[33] D. Ouwens,et al. Phosphorylation of PRAS40 on Thr246 by PKB/AKT facilitates efficient phosphorylation of Ser183 by mTORC1. , 2010, Cellular signalling.
[34] S. Nagata,et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD , 1998, Nature.
[35] C. Lang,et al. Alcohol and PRAS40 knockdown decrease mTOR activity and protein synthesis via AMPK signaling and changes in mTORC1 interaction , 2010, Journal of cellular biochemistry.
[36] John M Asara,et al. Insulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation* , 2003, The Journal of Biological Chemistry.
[37] M. Birnbaum,et al. Construction and Characterization of a Conditionally Active Version of the Serine/Threonine Kinase Akt* , 1998, The Journal of Biological Chemistry.
[38] J. Zierath,et al. Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients. , 2000, Diabetes.
[39] Gavin W. Porter,et al. Expression of proline-rich Akt-substrate PRAS40 in cell survival pathway and carcinogenesis , 2005, Acta Pharmacologica Sinica.
[40] A. Nakashima,et al. The Proline-rich Akt Substrate of 40 kDa (PRAS40) Is a Physiological Substrate of Mammalian Target of Rapamycin Complex 1* , 2007, Journal of Biological Chemistry.
[41] A. V. D. van den Ouweland,et al. Identification and Characterization of the Interaction between Tuberin and 14-3-3ζ* , 2002, The Journal of Biological Chemistry.
[42] R. Roth,et al. On the Mechanism for Neomycin Reversal of Wortmannin Inhibition of Insulin Stimulation of Glucose Uptake* , 2004, Journal of Biological Chemistry.
[43] J. Testa,et al. A Portrait of AKT Kinases: Human Cancer and Animal Models Depict a Family with Strong Individualities , 2004, Cancer biology & therapy.
[44] S. Kropf,et al. Different Activation of Mitogen-Activated Protein Kinase and Akt Signaling Is Associated with Aggressive Phenotype of Human Meningiomas , 2005, Clinical Cancer Research.
[45] A. Newton,et al. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. , 2005, Molecular cell.
[46] W. Aird,et al. The Akt-regulated Forkhead Transcription Factor FOXO3a Controls Endothelial Cell Viability through Modulation of the Caspase-8 Inhibitor FLIP* , 2004, Journal of Biological Chemistry.
[47] T. McGraw,et al. Insulin stimulation of GLUT4 exocytosis, but not its inhibition of endocytosis, is dependent on RabGAP AS160. , 2004, Molecular biology of the cell.
[48] J E Paciga,et al. AKT1/PKBalpha kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. , 2001, The American journal of pathology.
[49] Michael B Yaffe,et al. How do 14‐3‐3 proteins work? – Gatekeeper phosphorylation and the molecular anvil hypothesis , 2002, FEBS letters.
[50] Timothy J. Griffin,et al. Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40 , 2007, Nature Cell Biology.
[51] P. Graves,et al. 14-3-3 Proteins Are Required for Maintenance of Raf-1 Phosphorylation and Kinase Activity , 1998, Molecular and Cellular Biology.
[52] A. Saito,et al. Increased Expression of a Proline-Rich Akt Substrate (PRAS40) in Human Copper/Zinc-Superoxide Dismutase Transgenic Rats Protects Motor Neurons from Death after Spinal Cord Injury , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[53] K. M. Nicholson,et al. The protein kinase B/Akt signalling pathway in human malignancy. , 2002, Cellular signalling.
[54] I. Roninson,et al. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. , 2001, Genes & development.
[55] J. Avruch,et al. 14-3-3 Proteins: Active Cofactors in Cellular Regulation by Serine/Threonine Phosphorylation* , 2002, The Journal of Biological Chemistry.
[56] N. Sonenberg,et al. mTOR, translation initiation and cancer , 2006, Oncogene.
[57] P. Dennis,et al. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. , 2001, Cancer research.
[58] Hui-yu Liu,et al. Regulation of Interleukin-6-induced Hepatic Insulin Resistance by Mammalian Target of Rapamycin through the STAT3-SOCS3 Pathway* , 2008, Journal of Biological Chemistry.
[59] R. Memmott,et al. The Role of the Akt/mTOR Pathway in Tobacco Carcinogen–Induced Lung Tumorigenesis , 2009, Clinical Cancer Research.
[60] S. Bao,et al. The activation of Akt/PKB signaling pathway and cell survival , 2005, Journal of cellular and molecular medicine.
[61] M. Birnbaum,et al. Identification of a Proline-rich Akt Substrate as a 14-3-3 Binding Partner* , 2003, The Journal of Biological Chemistry.
[62] G. Robertson. Functional and therapeutic significance of Akt deregulation in malignant melanoma , 2005, Cancer and Metastasis Reviews.
[63] C. MacKintosh,et al. Differential 14-3-3 Affinity Capture Reveals New Downstream Targets of Phosphatidylinositol 3-Kinase Signaling* , 2009, Molecular & Cellular Proteomics.
[64] M. Yaffe,et al. The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity , 1997, Cell.
[65] Steven P Gygi,et al. Large-scale characterization of HeLa cell nuclear phosphoproteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[66] John Calvin Reed,et al. Regulation of cell death protease caspase-9 by phosphorylation. , 1998, Science.
[67] P. Workman,et al. Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930 , 2010, Molecular Cancer Therapeutics.
[68] H. Guan,et al. Sphingosine Kinase 1 Regulates the Akt/FOXO3a/Bim Pathway and Contributes to Apoptosis Resistance in Glioma Cells , 2011, PloS one.
[69] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[70] I. Yang,et al. The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments. , 2011, Neurosurgical focus.
[71] S. R. Datta,et al. Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.
[72] Jonathan R. Brestoff,et al. Rapamycin does not improve insulin sensitivity despite elevated mammalian target of rapamycin complex 1 activity in muscles of ob/ob mice. , 2008, American journal of physiology. Regulatory, integrative and comparative physiology.
[73] Wenhua Zheng,et al. Insulin-like growth factor-1-induced phosphorylation of transcription factor FKHRL1 is mediated by phosphatidylinositol 3-kinase/Akt kinase and role of this pathway in insulin-like growth factor-1-induced survival of cultured hippocampal neurons. , 2002, Molecular Pharmacology.
[74] M. Hung,et al. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells , 2001, Nature Cell Biology.
[75] P. Hornbeck,et al. Phosphoprotein Analysis Using Antibodies Broadly Reactive against Phosphorylated Motifs* , 2002, The Journal of Biological Chemistry.
[76] Toshiyuki Obata,et al. Peptide and Protein Library Screening Defines Optimal Substrate Motifs for AKT/PKB* , 2000, The Journal of Biological Chemistry.
[77] G. Robertson,et al. PRAS40 deregulates apoptosis in malignant melanoma. , 2007, Cancer research.
[78] Mahlon D. Johnson,et al. Increased STAT-3 and synchronous activation of Raf-1-MEK-1-MAPK, and phosphatidylinositol 3-Kinase-Akt-mTOR pathways in atypical and anaplastic meningiomas , 2008, Journal of Neuro-Oncology.
[79] S. Carr,et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. , 2007, Molecular cell.
[80] J. Olefsky,et al. Protein Phosphatase 2A Negatively Regulates Insulin's Metabolic Signaling Pathway by Inhibiting Akt (Protein Kinase B) Activity in 3T3-L1 Adipocytes , 2004, Molecular and Cellular Biology.
[81] J. Cheng,et al. Deregulated Akt3 Activity Promotes Development of Malignant Melanoma , 2004, Cancer Research.
[82] Huan Yang,et al. The Akt/PKB pathway: molecular target for cancer drug discovery , 2005, Oncogene.
[83] M. Yaffe,et al. A motif-based profile scanning approach for genome-wide prediction of signaling pathways , 2001, Nature Biotechnology.
[84] P. Sen,et al. Involvement of the Akt/PKB signaling pathway with disease processes , 2003, Molecular and Cellular Biochemistry.
[85] Howard L McLeod,et al. PI3K/Akt/mTOR pathway as a target for cancer therapy , 2005, Anti-cancer drugs.
[86] J. Woodgett,et al. PKB/AKT: functional insights from genetic models , 2001, Nature Reviews Molecular Cell Biology.
[87] D. Meredith,et al. Extracellular and subcellular regulation of the PI3K/Akt cassette: new mechanisms for controlling insulin and growth factor signalling. , 2007, Biochemical Society transactions.
[88] Atsushi Saito,et al. Neuroprotective Role of a Proline-Rich Akt Substrate in Apoptotic Neuronal Cell Death after Stroke: Relationships with Nerve Growth Factor , 2004, The Journal of Neuroscience.
[89] V. Steele,et al. Targeting the AKT protein kinase for cancer chemoprevention , 2007, Molecular Cancer Therapeutics.